Literature DB >> 11984669

Effects of carbon dioxide pneumoperitoneum on hemodynamics in cirrhotic rats.

S Tsuboi1, S Kitano, T Yoshida, T Bandoh, K Ninomiya, D Baatar.   

Abstract

BACKGROUND: The aim of our study was to investigate the effect of carbon dioxide pneumoperitoneum on systemic and splanchnic hemodynamics in cirrhotic rats.
METHODS: Sprague-Dawley rats (n = 80) were used in this study. Liver cirrhosis was induced by thioacetamide administration intraperitoneally (200 mg/kg body weight, twice a week for 16 weeks). The radioactive microsphere method was used to measure systemic and regional hemodynamic parameters before, 1 h after the start, and 1 h after the release of pneumoperitoneum.
RESULTS: Splanchnic blood flow and cardiac index were significantly depressed during pneumoperitoneum in liver cirrhosis and control groups, but no significant differences were seen between the two groups. In both groups, portal venous inflow decreased and hepatic arterial blood flow increased significantly during pneumoperitoneum. However, during pneumoperitoneum, total hepatic blood flow as a percentage of its value before pneumoperitoneum was lower in cirrhotic rats (71.0%) than in control rats (91.9%) (p <0.05, Mann-Whitney U-test).
CONCLUSIONS: Carbon dioxide pneumoperitoneum markedly decreases total hepatic blood flow in cirrhotic rats due to the impaired hepatic arterial buffer response. Liver function should be carefully controlled in cirrhotic patients after laparoscopic surgery with pneumoperitoneum.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11984669     DOI: 10.1007/s00464-001-9163-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  9 in total

Review 1.  Regulation of hepatic blood flow: the hepatic arterial buffer response revisited.

Authors:  Christian Eipel; Kerstin Abshagen; Brigitte Vollmar
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  CO(2) pneumoperitoneum increases secretory IgA levels in the gut compared with laparotomy in an experimental animal model.

Authors:  Toru Kusano; Tsuyoshi Etoh; Masafumi Inomata; Norio Shiraishi; Seigo Kitano
Journal:  Surg Endosc       Date:  2014-01-18       Impact factor: 4.584

3.  Cirrhosis is not a contraindication to laparoscopic surgery.

Authors:  W S Cobb; B T Heniford; J M Burns; A M Carbonell; B D Matthews; K W Kercher
Journal:  Surg Endosc       Date:  2004-12-23       Impact factor: 4.584

4.  Risk Factors for Postoperative Liver Enzyme Elevation After Laparoscopic Gastrectomy for Gastric Cancer.

Authors:  Akihiko Sano; Kana Saito; Kengo Kuriyama; Nobuhiro Nakazawa; Yasunari Ubukata; Keigo Hara; Makoto Sakai; Kyoichi Ogata; Takaharu Fukasawa; Makoto Sohda; Minoru Fukuchi; Hiroshi Naitoh; Ken Shirabe; Hiroshi Saeki
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

5.  Changes in the level of serum liver enzymes after laparoscopic surgery.

Authors:  Min Tan; Feng-Feng Xu; Jun-Shen Peng; Dong-Ming Li; Liu-Hua Chen; Bao-Jun Lv; Zhen-Xian Zhao; Chen Huang; Chao-Xu Zheng
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

6.  The impact of carbon dioxide pneumoperitoneum on liver regeneration after liver resection in a rat model.

Authors:  S C Schmidt; G Schumacher; N Klage; S Chopra; P Neuhaus; U Neumann
Journal:  Surg Endosc       Date:  2009-06-17       Impact factor: 4.584

7.  Regulatory processes interacting to maintain hepatic blood flow constancy: Vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction.

Authors:  W Wayne Lautt
Journal:  Hepatol Res       Date:  2007-11       Impact factor: 4.288

8.  Transient liver dysfunction after laparoscopic gastrectomy for gastric cancer patients.

Authors:  Tsuyoshi Etoh; Norio Shiraishi; Masaaki Tajima; Akio Shiromizu; Kazuhiro Yasuda; Masafumi Inomata; Seigo Kitano
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

9.  Comparison of liver function after laparoscopically assisted and open distal gastrectomies for patients with liver disease.

Authors:  Hong Man Yoon; Han-Kwang Yang; Hyuk-Joon Lee; Do Joong Park; Hyung-Ho Kim; Kuhn-Uk Lee; Hye Seong Ahn; Jae-Jin Jo
Journal:  Surg Endosc       Date:  2011-03-18       Impact factor: 4.584

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.